Hyperion Defi (HYPD) Common Equity (2016 - 2026)
Hyperion Defi (HYPD) posted quarterly Common Equity of $58.5 million for Q1 2026, up 702.17% year-over-year from $7.3 million in Q1 2025, and up 42.46% quarter-over-quarter from $41.1 million in Q4 2025.
Hyperion Defi (HYPD) Common Equity (2016 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Common Equity for 11 consecutive years, with $58.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity rose 702.17% year-over-year to $58.5 million; the TTM figure through Mar 2026 stood at $58.5 million (up 702.17% YoY), while the FY2025 annual figure was $41.1 million, up 413.54% from the prior year.
- Common Equity grew to $58.5 million in Q1 2026 per HYPD's latest filing, from $41.1 million in the prior quarter.
- Across five years, Common Equity topped out at $70.8 million in Q3 2025 and bottomed at -$13.1 million in Q4 2024.
- Historically, Common Equity has averaged $19.4 million across 5 years, with a median of $15.8 million in 2023.
- On a YoY basis, Common Equity climbed as much as 1802.37% in 2025 and fell as far as 634.39% in 2025.
- Hyperion Defi's Common Equity stood at $17.2 million in 2022, then sank by 47.78% to $9.0 million in 2023, then slumped by 245.53% to -$13.1 million in 2024, then surged by 413.54% to $41.1 million in 2025, then jumped by 42.46% to $58.5 million in 2026.
- Business Quant data shows HYPD's Common Equity at $58.5 million in Q1 2026, $41.1 million in Q4 2025, and $70.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.35 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 757.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.79 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 22.38 Bn |
| 10 | Hyperion Defi | 44.65 Mn | 35.01 Mn | 357,693.00 | 101.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 101.93 Mn |
| Mar 31, 2026 | 58.49 Mn |
| Dec 31, 2025 | 41.06 Mn |
| Sep 30, 2025 | 70.76 Mn |
| Jun 30, 2025 | 37.36 Mn |
| Mar 31, 2025 | -9.71 Mn |
| Dec 31, 2024 | -13.10 Mn |
| Sep 30, 2024 | 3.72 Mn |
| Jun 30, 2024 | -2.37 Mn |
| Mar 31, 2024 | 1.82 Mn |
| Dec 31, 2023 | 9.00 Mn |
| Sep 30, 2023 | 15.78 Mn |
| Jun 30, 2023 | 10.52 Mn |
| Mar 31, 2023 | 15.81 Mn |
| Dec 31, 2022 | 17.23 Mn |
| Sep 30, 2022 | 20.33 Mn |
| Jun 30, 2022 | 23.61 Mn |
| Mar 31, 2022 | 29.79 Mn |
| Dec 31, 2021 | 20.47 Mn |
| Sep 30, 2021 | 4.25 Mn |